FRONTIER MEDICINES Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for FRONTIER MEDICINES with the United States Patent and Trademark Office. The USPTO has given the FRONTIER MEDICINES trademark a serial number of 90112724. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2024. This trademark is owned by Frontier Medicines Corporation. The FRONTIER MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Small molecule pharmaceuticals for the treatment of cancer, heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans

pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer
frontier medicines

General Information

Serial Number90112724
Word MarkFRONTIER MEDICINES
Filing DateThursday, August 13, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements

Description of MarkThe mark consists of an egg-shaped design, the inside portion depicting an image of a winding stream or road, next to the word "FRONTIER" in large font. Below "FRONTIER" appears the word "MEDICINES" in smaller font.
Goods and ServicesSmall molecule pharmaceuticals for the treatment of cancer, heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans
NOT AVAILABLE"MEDICINES"
Goods and Servicespharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 16, 2020
Primary Code042
First Use Anywhere DateMonday, September 30, 2019
First Use In Commerce DateMonday, September 30, 2019

Trademark Owner History

Party NameFrontier Medicines Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFrontier Medicines Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, August 17, 2020NEW APPLICATION ENTERED
Wednesday, September 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 17, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 8, 2020ASSIGNED TO EXAMINER
Tuesday, December 15, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 15, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 4, 2021LETTER OF SUSPENSION E-MAILED
Friday, June 4, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 4, 2021SUSPENSION LETTER WRITTEN
Monday, December 6, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, December 15, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 15, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, December 15, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, December 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 27, 2022SOU EXTENSION 1 FILED
Tuesday, September 27, 2022SOU EXTENSION 1 GRANTED
Thursday, September 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 2 FILED
Friday, March 31, 2023SOU EXTENSION 2 GRANTED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 8, 2023SOU EXTENSION 3 FILED
Friday, September 8, 2023SOU EXTENSION 3 GRANTED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 28, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, December 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 6, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

medicines frontier disease diseases cancer research pharmaceutical development pharmaceuticals treatment asthma allergies